Buprenorphine Withdrawal Management

Tapering Strategies

For patients discontinuing Suboxone, a slow taper using divided doses of buprenorphine combined with symptomatic management is the recommended approach, though evidence suggests shorter tapers may be as effective as longer tapers for preventing relapse 1

Clonidine or lofexidine can be used as adjunctive therapy to manage autonomic withdrawal symptoms, though they are less effective than buprenorphine itself for opioid withdrawal 1
These medications address symptoms such as sweating, tachycardia, hypertension, and anxiety 1
Use the Clinical Opiate Withdrawal Scale (COWS) to objectively assess withdrawal severity and guide treatment decisions 1, 2
Mild withdrawal (COWS <8) may not require pharmacological intervention beyond symptomatic support 1

If a patient needs to restart buprenorphine after using full opioid agonists during or after taper, they must be in mild to moderate opioid withdrawal before buprenorphine administration to avoid precipitated withdrawal 1, 2, 3
Wait at least 12 hours after short-acting opioids, 24 hours after extended-release formulations, or 72 hours after methadone before restarting buprenorphine 1

Provide naloxone kits for overdose prevention, as patients discontinuing buprenorphine face increased overdose risk if they return to illicit opioid use 1, 2
Offer hepatitis C and HIV screening during the withdrawal process 1, 2
Ensure access to behavioral health support and counseling, as medication alone has poor long-term outcomes 1